Galectin Therapeutics reported $100.4M in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US $ 270.65B 15.68B
Bristol Myers Squibb BMY:US $ 163.94B 8.45B
Galectin Therapeutics GALT:US $ 0.08B 0.02B
Gilead Sciences GILD:US $ 77.53B 2.87B
Idera Pharmaceuticals IDRA:US $ 0.02B 0B
Intercept Pharmaceuticals ICPT:US $ 0.41B 0.07B
Merk MRK:US $ 230.55B 23.1B
Regulus Therapeutics RGLS:US $ 0.03B 0.01B
Vital Therapies VTL:US $ 0.08B 0.25B
YTE INCY:US $ 16.83B 0.75B